Pharmsynthez reported earnings results for the six months of 2016. The company's net profit of RUB 512.38 million to International Financial Reporting Standards, compared with losses of RUB 282.984 million a year previously. Sales revenue fell 6.7% year-on-year to RUB 192.928 million. The company had operating profit of RUB 727.366 million, compared with losses of RUB 281.004 million a year previously. Pre-tax profit was RUB 727.366 million, compared with losses of RUB 278.827 million.